Type 2 Diabetes Management and the Impact of 'Mounjaro'

What is Type 2 Diabetes?

Type 2 Diabetes (T2D) is a chronic condition characterized by insulin resistance and insufficient insulin secretion. It mainly affects adults and is commonly caused by obesity, lack of exercise, and genetic factors. Those who are overweight have a higher risk of developing this condition.

 

Key Symptoms

 

• Frequent urination and thirst
• Fatigue and unexplained weight loss
• Blurred vision

Importance of Management

Proper weight control and blood sugar management are crucial for T2D patients, especially those who are obese, to reduce cardiovascular risks.

Effectiveness of 'Mounjaro'

Korean pharma company Lilly recently introduced 'Mounjaro', a GIP/GLP-1 dual agonist proven to reduce HbA1c levels by up to 2.4% and achieve weight loss of 9-11 kg in clinical trials.

 

Expert Insights

• Dr. Hyuk-Sang Kwon: "Effective treatment is needed for both weight and glucose control."
• Dr. Sung-Hee Choi: "'Mounjaro' could be a game-changer for patients struggling with obesity and T2D."

Effective management of T2D with therapies like 'Mounjaro' can significantly enhance patients' quality of life, addressing both glucose and weight management needs.

Reference Sites
Medical World News
Korean Diabetes Association